Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-28 06:00 am Purchase | 2023-11-22 | 13D | Atea Pharmaceuticals, Inc. AVIR | TANG CAPITAL PARTNERS LP | 4,033,463 4.800% | 1,007,008 (+33.27%) | Filing History |
| 2023-11-07 3:33 pm Purchase | 2023-10-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 8,838,015 10.600% | 804,443 (+10.01%) | Filing History |
| 2023-10-02 11:45 am Purchase | 2023-09-25 | 13G | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 4,183,645 5.000% | 4,183,645 (New Position) | Filing History |
| 2023-09-11 08:23 am Sale | 2023-09-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 7,074,287 8.482% | -4,663,122 (-39.73%) | Filing History |
| 2023-05-22 09:00 am Purchase | 2023-05-22 | 13D | Atea Pharmaceuticals, Inc. AVIR | TANG CAPITAL PARTNERS LP | 3,026,455 3.600% | 3,026,455 (New Position) | Filing History |
| 2023-02-10 4:15 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | JPM Partners LLC | 7,474,882 8.800% | 374,883 (+5.28%) | Filing History |
| 2023-02-10 1:37 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,184,861 7.400% | 808,727 (+15.04%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | The Vanguard Group | 6,089,522 7.310% | 307,640 (+5.32%) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 11,737,409 14.092% | -728,000 (-5.84%) | Filing History |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 8,033,572 9.600% | 2,252,375 (+38.96%) | Filing History |
| 2022-02-16 4:00 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 0 0.000% | -6,634,956 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,368,451 (Position Closed) | Filing History |
| 2022-02-14 3:05 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management, LP | 1,679,442 2.020% | -4,731,913 (-73.81%) | Filing History |
| 2022-02-10 4:15 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | JPM Partners LLC | 7,099,999 8.400% | 298,335 (+4.39%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | The Vanguard Group | 5,781,882 6.960% | 5,781,882 (New Position) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 12,465,409 14.999% | 3,879,374 (+45.18%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 5,781,197 7.000% | 5,781,197 (New Position) | Filing History |
| 2021-12-10 5:08 pm Purchase | 2021-12-01 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 5,376,134 6.500% | 5,376,134 (New Position) | Filing History |
| 2021-09-24 5:15 pm Sale | 2021-09-22 | 13D | Atea Pharmaceuticals, Inc. AVIR | Bain Capital Life Sciences Fund II, L.P. | 3,178,532 3.800% | -846,856 (-21.04%) | Filing History |
| 2021-09-03 5:00 pm Sale | 2021-09-01 | 13D | Atea Pharmaceuticals, Inc. AVIR | Bain Capital Life Sciences Fund II, L.P. | 4,025,388 4.900% | -757,714 (-15.84%) | Filing History |